ArticleInfection and immunity2011

An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation.

Athanasios Paschos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.